arrow
C

Claudia Petritsch

stanford university school of medicine
H指数:28
被引数:6,009

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

BRAF-altered glioma in adults and children: A Society for Neuro-Oncology and European Association of Neuro-Oncology consensus review on clinical management and future directions

BRAF突变型胶质瘤在成人和儿童中的研究:神经肿瘤学会和欧洲神经肿瘤学会关于临床管理与未来方向的共识综述

2026-06-080
OAAI
A spatially resolved human glioblastoma atlas reveals distinct cellular and molecular patterns of anatomical niches

空间分辨的人类胶质母细胞瘤图谱揭示了解剖微环境中独特的细胞和分子模式

2026-02-200
OA
COMPARATIVE PATHOLOGY OF A RAREMN1::PATZ1-FUSION NEUROEPITHELIAL PRIMARY TUMOR AND RECURRENCE DEMONSTRATING MARKED HETEROGENEITY, POTENTIAL CHANGES IN TUMOR IMMUNE COMPOSITION, AND CELL-STATE TRANSITIONS

一种罕见的MN1::PATZ1融合神经上皮原发性肿瘤及其复发的比较病理学研究,显示出显著异质性、肿瘤免疫成分的潜在变化以及细胞状态转换

2025-11-010
OAAI
Quantitative surfaceome profiling of high-risk medulloblastoma prioritizes the oncofetal antigen GPC2 for potent CAR-T cell therapy

高风险髓母细胞瘤的定量表面组分析优先考虑癌胚抗原GPC2用于有效的CAR-T细胞疗法

2025-11-010
OAAI
Inflammation-driven Resistance to MAPK inhibition in Pediatric Gliomas: Mechanisms and Therapeutic Strategies

炎症驱动的MAPK抑制耐药性在儿童胶质瘤中的机制与治疗策略

2025-11-010
OAAI
LEVETIRACETAM THERAPEUTICALLY TARGETS GABAERGIC SYNAPSES IN DIFFUSE MIDLINE GLIOMA

左乙拉西坦通过治疗作用靶向弥漫性中线胶质瘤中的GABA能突触

2025-11-010
OAAI
Dynamic kinome reprogramming drives resistance to treatments in BRAFV600E pediatric gliomas, revealing actionable therapeutic vulnerabilities

动态激酶组重编程驱动BRAFV600E儿童胶质瘤对治疗的耐药性,揭示了可操作的 therapeutic vulnerabilities。

2025-11-010
OAAI
BRAF/MEK inhibition induces cell state transitions boosting immune checkpoint sensitivity in BRAFV600E-mutant glioma

BRAF/MEK抑制诱导BRAFV600E突变型胶质瘤细胞状态转变,增强免疫检查点敏感性

2025-06-120
OA
CDC42BPA::BRAF represents a novel fusion in desmoplastic infantile ganglioglioma/desmoplastic infantile astrocytoma

CDC42BPA::BRAF代表了增生性婴儿神经节神经胶质瘤/增生性婴儿星形细胞瘤的新型融合

2024-03-300
OAAI